Biogen (NASDAQ:BIIB) Price Target Cut to $210.00 by Analysts at Truist Financial
Biogen (NASDAQ:BIIB – Free Report) had its target price lowered by Truist Financial from $220.00 to $210.00 in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other analysts also recently issued reports on the company. Stifel Nicolaus downgraded […]
Biogen (NASDAQ:BIIB – Free Report) had its target price lowered by Truist Financial from $220.00 to $210.00 in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other analysts also recently issued reports on the company. Stifel Nicolaus downgraded […]
